← brief for 2026-11-01 · Slowing decline

Disease-Targeted Therapies and eGFR Slope over 2 Years in IgA Nephropathy: A Systematic Review and Network Meta-Analysis

Preprint A Not peer reviewed Meta-analysis or large trial

Key takeaways

This review compared several new drugs for IgA nephropathy, a common cause of kidney disease. It found that all the drugs slowed the drop in kidney filtering rate over two years. The drugs helped by different amounts, with some working better than others. This is a high-level review of large trials, so it is strong evidence for people with this specific condition.

Source

Preprint · medRxiv nephrology preprints · 2026-11-01
https://www.medrxiv.org/content/10.64898/2026.10.29.26366792v1?rss=1